NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP LIQUID Kanada - angličtina - Health Canada

neostigmine methylsulfate inj 1mg/ml usp liquid

david bull laboratories (pty) ltd. - neostigmine methylsulfate - liquid - 1mg - neostigmine methylsulfate 1mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP LIQUID Kanada - angličtina - Health Canada

neostigmine methylsulfate inj 0.5mg/ml usp liquid

david bull laboratories (pty) ltd. - neostigmine methylsulfate - liquid - .5mg - neostigmine methylsulfate .5mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE INJECTION LIQUID Kanada - angličtina - Health Canada

neostigmine methylsulfate injection liquid

fresenius kabi canada ltd - neostigmine methylsulfate - liquid - 1mg - neostigmine methylsulfate 1mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE INJECTION LIQUID Kanada - angličtina - Health Canada

neostigmine methylsulfate injection liquid

fresenius kabi canada ltd - neostigmine methylsulfate - liquid - 0.5mg - neostigmine methylsulfate 0.5mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE INJECTION SDZ SOLUTION Kanada - angličtina - Health Canada

neostigmine methylsulfate injection sdz solution

sandoz canada incorporated - neostigmine methylsulfate - solution - 0.5mg - neostigmine methylsulfate 0.5mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE INJECTION SDZ SOLUTION Kanada - angličtina - Health Canada

neostigmine methylsulfate injection sdz solution

sandoz canada incorporated - neostigmine methylsulfate - solution - 2.5mg - neostigmine methylsulfate 2.5mg - parasympathomemetic (cholinergic) agents

NEOSTIGMINE METHYLSULFATE 0.5 MG/ML AMPOULE Solution for injection Saudská Arábia - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

neostigmine methylsulfate 0.5 mg/ml ampoule solution for injection

alamriah for pharmaceuticals industries, egypt - neostigmine methylsulfate - solution for injection - 0.5 mg/ml

GLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

glneo 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 ml solution for injection ampoule

ksj pharmatech - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid; dibasic sodium phosphate dodecahydrate - reversal of residual non-depolarising (competitive) neuromuscular block.

AMEZINIUM METILSULFATE TABLETS 10mg "TOWA" (アメジニウムメチル硫酸塩錠10mg「トーワ」) Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

amezinium metilsulfate tablets 10mg "towa" (アメジニウムメチル硫酸塩錠10mg「トーワ」)

towa pharmaceutical co., ltd. - amezinium metilsulfate - white tablet with split line, diameter: 6.5 mm, thickness: 2.3 mm

Vimizim Európska únia - angličtina - EMA (European Medicines Agency)

vimizim

biomarin international limited - recombinant human n-acetylgalactosamine-6-sulfatase - mucopolysaccharidosis iv - other alimentary tract and metabolism products, - vimizim is indicated for the treatment of mucopolysaccharidosis, type iva (morquio a syndrome, mps iva) in patients of all ages.